Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Mar 26, 2018. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-3796-01
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)
Initial Posting
Mar 26, 2018

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.